Trial intelligence / Profile preview

AND017 in non-dialysis CKD anemia (phase 2, placebo-controlled)

CTR20211873Phase 2Completed

Sponsor
Kind Pharmaceuticals LLC
Start
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of AND017 in anaemia, sponsored by Kind Pharmaceuticals LLC. Started Aug 2021; status: completed.

02

Drugs

AND017
03

Conditions

anaemia

Beyond the preview

Go deeper on CTR20211873.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20211873.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call